Friend or foe? The elusive role of hepatic stellate cells in liver cancer
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Liver fibrosis is a substantial risk factor for the development and progression of liver cancer, which includes hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). Studies utilizing cell fate mapping and single-cell transcriptomics techniques have identified quiescent perisinusoidal hepatic stellate cells (HSCs) as the primary source of activated collagen-producing HSCs and liver cancer-associated fibroblasts (CAFs) in HCC and liver metastasis, complemented in iCCA by contributions from portal fibroblasts. At the same time, integrative computational analysis of single-cell, single-nucleus and spatial RNA sequencing data have revealed marked heterogeneity among HSCs and CAFs, with distinct subpopulations displaying unique gene expression signatures and functions. Some of these subpopulations have divergent roles in promoting or inhibiting liver fibrogenesis and carcinogenesis. In this Review, we discuss the dual roles of HSC subpopulations in liver fibrogenesis and their contribution to liver cancer promotion, progression and metastasis. We review the transcriptomic and functional similarities between HSC and CAF subpopulations, highlighting the pathways that either promote or prevent fibrosis and cancer, and the immunological landscape from which these pathways emerge. Insights from ongoing studies will yield novel strategies for developing biomarkers, assessing prognosis and generating new therapies for both HCC and iCCA prevention and treatment. Hepatic stellate cells (HSCs) drive liver fibrosis and are closely linked to liver cancer development. This comprehensive Review provides an in-depth analysis of the specific characteristics of HSCs in cancer, highlighting therapeutic implications based on progress in clarifying HSC biology. Hepatic stellate cells (HSCs) are the major source of activated myofibroblast-like cells in liver fibrosis and cancer-associated fibroblasts (CAFs) in both primary and metastatic liver cancer. Single-cell resolution technologies are unveiling the transcriptomic and phenotypic heterogeneity of HSCs and CAFs in mouse models of liver disease and in humans. Specific subpopulations of HSCs and CAFs exhibit contrasting tumour-promoting and tumour-inhibitory functions based on their immunological and tumour-specific context. HSC subpopulations with unique secretomes, including activated HSCs, senescent HSCs and CAFs, are promising targets for antifibrotic therapies that might reduce the risk of liver cancer, especially in patients with nonalcoholic steatohepatitis. Hepatic stellate cells (HSCs) are the major source of activated myofibroblast-like cells in liver fibrosis and cancer-associated fibroblasts (CAFs) in both primary and metastatic liver cancer. Single-cell resolution technologies are unveiling the transcriptomic and phenotypic heterogeneity of HSCs and CAFs in mouse models of liver disease and in humans. Specific subpopulations of HSCs and CAFs exhibit contrasting tumour-promoting and tumour-inhibitory functions based on their immunological and tumour-specific context. HSC subpopulations with unique secretomes, including activated HSCs, senescent HSCs and CAFs, are promising targets for antifibrotic therapies that might reduce the risk of liver cancer, especially in patients with nonalcoholic steatohepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979 · cited 1×
“Stiff substrates activate integrins 158 , FAK 159 , SRC family kinases 160 and YAP–TAZ 161 signalling, which in turn promote the expression of pro-proliferative and pro-migratory genes in both cancer cells and stromal cells 162 .”
BackgroundTGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400 · cited 10×
“Other emerging approaches to locally inhibit TGFβ, include targeting caveolin (which internalizes the TGFβ receptor) 211 , hyaluronic acid synthase 2 (which activates HSCs) 212 , CD147 (which triggers HSC contraction, migration and expression of fibrogenic genes) 213 , hydrogen peroxide inducible clone 5 (important fo…”
BackgroundInfluentialThe pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“CAFs can therefore generate a permissive TME through the recruitment of myeloid cells and immunosuppression of T cell activity, key hallmarks of cancer 176,177 , and thereby decrease immune surveillance and promote tumour cell escape.”
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Tensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941 · cited 1×
“Stiff substrates activate integrins 158 , FAK 159 , SRC family kinases 160 and YAP–TAZ 161 signalling, which in turn promote the expression of pro-proliferative and pro-migratory genes in both cancer cells and stromal cells 162 .”
BackgroundA framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Cited by
Cell senescence in liver diseases: pathological mechanism and theranostic opportunity
Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00913-4 · Cited by 117
“Conversely, HSCs lacking functional p53 secrete specific factors that facilitate the polarization of macrophages towards a tumour-promoting phenotype through the secretion of IL-33, therefore enhancing the proliferation of premalignant cells 93–95 .”
Schwabe, R. F., & Brenner, D. A. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01068-6 · Cited by 112
Liver macrophages: development, dynamics, and functions
Nusse, Y., & Kubes, P. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01298-3 · Cited by 50
Khanal, S., Liu, Y., Bamidele, A. O., Wixom, A. Q., Washington, A. M., Jalan-Sakrikar, N., Cooper, S. A., Vuckovic, I., Zhang, S., Zhong, J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn5228 · Cited by 41
Yashaswini, C. N., Cogliati, B., Qin, T., To, T., Williamson, T., Papp, T. E., Li, K., Rasul, R., Chen, L., Lightstone, A., et al. (2025) · doi:10.1101/2025.02.25.640143 · Cited by 13
Self-citation
Metadata
- Authors
- Cogliati, B., Yashaswini, C. N., Wang, S., Sia, D., & Friedman, S. L.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2023-08-07
- Volume
- 20
- Issue
- 10
- Pages
- 647-661
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4385636695
- Cited by
- 148
- References
- 90
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Friend or foe? The elusive role of hepatic stellate cells in liver cancer. https://app.cochat.ai/papers/10.1038/s41575-023-00821-z
- The paper
- Cogliati, B., Yashaswini, C. N., Wang, S., Sia, D., & Friedman, S. L. (2023). Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-023-00821-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.